Catalyst Wire Dossier Catalyst Wire Dossier

HX575

epoetin alfa · Sandoz
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HX575, covering 2015-06-02 to 2017-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients [Phase 3]

See pricing